106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2015 All rights reserved
ATAREC15082
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient care.
It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be
considered exclusive of other methods of care reasonably directed at obtaining the same results. e
ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer
consideration of each individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service associated with
the distributor of this clinical reference tool.
Abbreviations
DTC, differentiated thyroid cancer; RLN, recurrent laryngeal nerve; FDG,
18F-Fluorodeoxyglucose; PET, positron emission tomography
Source
Tufano RP, Clayman G, Heller KS, et al. Management of recurrent/persistent nodal disease
in patients with differentiated thyroid cancer: a critical review of the risks and benefits of
surgical intervention versus active surveillance. yroid, a Mary Ann Liebert, Inc. publication.
2015;25(1):15-27.
American yroid Association, Inc.
6066 Leesburg Pike, Suite 550 • Falls Church, Virginia 22041
Phone: 703.998.8890 • Fax: 703.998.8893 • www.thyroid.org
Physician referral, patient resources available online in English and Spanish.
